Cerebrospinal fluid levels of thiamine in patients with Parkinson's disease

Neuroscience Letters

Volumn 271, Issue 1, 1999, Pages 33-36

  Jiménez Jiménez, Félix Javier ^a   Molina, José Antonio ^b   Hernánz, Angel ^c   Fernández Vivancos, Estrella ^c   De Bustos, Fernando ^b   Barcenilla, Beatriz ^a   Gómez Escalonilla, Carlos ^b   Zurdo, Martín ^a   Berbel, Angel ^b   Villanueva, Clara ^b  

^a HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c Ciudad Sanitaria La Paz ^*  (Spain)

Author keywords

Cerebrospinal fluid levels; Parkinson's disease; Thiamine

Indexed keywords

COCARBOXYLASE; THIAMINE; THIAMINE PHOSPHATE;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NERVE CELL DEGENERATION; PARKINSON DISEASE; PRIORITY JOURNAL; RISK FACTOR; SUBSTANTIA NIGRA; VITAMIN METABOLISM;

ANTIPARKINSON AGENTS; DOPAMINE AGONISTS; FEMALE; HUMANS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; REFERENCE VALUES; SELEGILINE; THIAMINE; THIAMINE MONOPHOSPHATE; THIAMINE PYROPHOSPHATE;

EID: 0344117554     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00515-7     Document Type: Article

References (18)

1. Baker H., Frank O., Chen T., Feingold S., DeAngelis B., Baker E. Vitamin content of some normal human segments. J. Neurosci. Res. 11:1984;419-435.
2. Bettendorff L., Goessens G., Sluse F., Wins P., Bureau M., Laschet J., Grisar T. Thiamine deficiency in cultured neuroblastoma cells: effect on mitochondrial function and peripheral benzodiazepine receptors. J. Neurochem. 64:1995;2013-2021.
3. Bettendorff L., Peeters M., Jouan C., Wins P., Schoffeniels E. Determination of thiamine and its phosphate esters in cultured neurons and astrocytes using an ion-pair reversed phase high performance liquid chromatography method. Ann. Biochem. 198:1991;52-59.
4. Bettendorff L., Wins P., Lesourd M. Subcellular localization and compartmentalization of thiamine derivatives in rat brain. Biochim. Biophys. Acta. 1222:1994;1-6.
5. Blass J.P. Vitamin and nutritional deficiencies. Siegel G.J., Agranoff B.W., Albers R.W., Molinoff P.B. Basic Neurochemistry. 1994;749-760 Raven Press, New York.
6. Fahn, S., Elton, R.L. and members of the UPDRS Development Committee, Unified Parkinson's Disease Rating Scale, In S. Fahn, C.D. Marsden, M. Goldstein and D.B. Calne (Eds.), Recent Developments in Parkinson's Disease, Vol. 2, MacMillan, Florham Park, NJ, 1987, pp. 153-163.
7. Gold M., Hauser R.A., Chen M.F. Plasma thiamine deficiency associated with Alzheimer's disease but not Parkinson's disease. Metab. Brain. Dis. 13:1998;43-53.
8. Hoehn M.M., Yahr M.D. Parkinsonism: onset, progression, and mortality. Neurology. 17:1967;419-423.
9. Hughes A.J., Ben-Shlomo S.E., Daniel S.E., Lees A.J. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathological study. Neurology. 42:1992;1142-1146.
10. Jiménez-Jiménez F.J., Ortí-Pareja M., Gasalla-González T. Epidemiología, etiología y patogenia de la enfermedad de Parkinson. Jiménez-Jiménez F.J., Luquin M.R., Molina J.A. Tratado de Los Trastornos del Movimiento. 1998;223-258 IM&C, Madrid.
11. Kobayashi T., Matsumine H., Matuda S., Mizuno Y. Association between the gene encoding the E2 subunit of the alfa-ketoglutarate dehydrogenase complex and Parkinson's disease. Ann. Neurol. 43:1998;120-123.
12. Lai J.C.K., Walsh J.M., Dennis S.C., Clark J.B. Synaptic and nonsynaptic mitochondria from rat brain: isolation and characterization. J. Neurochem. 28:1977;625-631.
13. Mizuno Y., Matuda S., Yoshino H., Mori H., Hattori N., Ikebe S.I. An immunohistochemical study on α-ketoglutarate dehydrogenase complex in Parkinson's disease. Ann. Neurol. 35:1994;204-210.
14. Moreu E., Molinero L.M., Fernández E. R-Sigma: Base de Datos Bioestadística para un Ordenador Personal. 1990;Horus Hardware, Madrid.
15. Munujos P., Coll-Canti J., Beleta J., González-Sastre F., Gella F.J. Brain pyruvate oxidation in experimental thiamin-deficiency encephalopathy. Clin. Chim. Acta. 255:1996;13-25.
16. Pedraza O.L., Botez M.I. Thiamine status in inherited degenerative ataxias. J. Neurol. Neurosurg. Psychiatry. 55:1992;136-137.
17. Rindi G., Patrini C., Poloni M. Monophosphate, the only phosphoric ester of thiamin in the cerebro-spinal fluid. Experientia. 37:1981;975-976.
18. Yamashita H., Zhang Y.X., Nakamura S. The effects of thiamine and its phosphate esters on dopamine release in the rat striatum. Neurosci. Lett. 158:1993;229-231.